A study for a 43 year old woman who takes Lo Loestrin Fe, Xyzal - from FDA reports


Summary

2 females aged 43 (±5) who take the same drugs are studied. This is a personalized study for a 43 year old female patient who has Birth Control, Seasonal Allergy. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Jun, 19, 2017

2 females aged 43 (±5) who takes Lo Loestrin Fe, Xyzal are studied.

Number of reports submitted per year:

Lo Loestrin Fe, Xyzal for a 43-year old woman.

Information of the patient in this study:

  • Age: 43
  • Gender: female
  • Conditions: Birth Control, Seasonal Allergy
  • Drugs taken:
    • Lo Loestrin Fe (ethinyl estradiol)
    • Xyzal (levocetirizine dihydrochloride)
  • Drug interactions: Raynaud's Syndrome, Dyshidrotic Eczema

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Raynaud's Syndrome: 0 (0% of females aged 43 (±5) who take the drugs)
  • Dyshidrotic Eczema: 0 (0% of females aged 43 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Top conditions involved for these people *:

  • Rheumatoid Arthritis (2 people, 100.00%)

Top co-used drugs for these people *:

  • Vitamin D (2 people, 100.00%)
  • Omnaris (2 people, 100.00%)
  • Enbrel (2 people, 100.00%)
  • Astelin (2 people, 100.00%)
  • Turmeric (1 person, 50.00%)

Top other side effects for these people *:

  • Rash Papular (1 person, 50.00%)
  • Rash Erythematous (1 person, 50.00%)
  • Injection Site Swelling (1 person, 50.00%)
  • Injection Site Irritation (1 person, 50.00%)
  • Injection Site Erythema (1 person, 50.00%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

What are the drugs?

What are the conditions?

What are the symptoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Xyzal, Raynaud's syndrome, Seasonal allergy, Dyshidrotic eczema, Birth control, Lo loestrin fe

You may be interested in these reviews

More reviews for: Xyzal, Raynaud's syndrome, Seasonal allergy, Dyshidrotic eczema, Birth control, Lo loestrin fe